Madrigal Pharmaceuticals, Inc. Insider Transactions
Purchase
Sell
Madrigal Pharmaceuticals, Inc. Insider Trades History
| Insider Name | Buy/Sell | Shares Bought/Sold @ Price |
Total Transaction | Shares Held After Transaction |
Transaction Date | Filing Date | Details |
|---|---|---|---|---|---|---|---|
|
CRAVES FRED B
Director |
Sell | 400 @ $328.68 | $131.47 K | 351,118 | 03/13/2025 | 03/14/2025 | |
|
CRAVES FRED B
Director |
Sell | 967 @ $329.86 | $318.98 K | 350,151 | 03/13/2025 | 03/14/2025 | |
|
CRAVES FRED B
Director |
Sell | 900 @ $324.69 | $292.22 K | 353,318 | 03/13/2025 | 03/14/2025 | |
|
CRAVES FRED B
Director |
Sell | 75 @ $330.23 | $24.77 K | 350,076 | 03/13/2025 | 03/14/2025 | |
|
CRAVES FRED B
Director |
Sell | 800 @ $325.63 | $260.50 K | 352,518 | 03/13/2025 | 03/14/2025 | |
|
CRAVES FRED B
Director |
Sell | 1,951 @ $322.45 | $629.10 K | 355,867 | 03/13/2025 | 03/14/2025 | |
|
CRAVES FRED B
Director |
Sell | 1,000 @ $327.63 | $327.63 K | 351,518 | 03/13/2025 | 03/14/2025 | |
|
CRAVES FRED B
Director |
Sell | 1,649 @ $323.47 | $533.39 K | 354,218 | 03/13/2025 | 03/14/2025 | |
|
CRAVES FRED B
Director |
Sell | 2,759 @ $331.36 | $914.22 K | 353,458 | 03/12/2025 | 03/14/2025 | |
|
CRAVES FRED B
Director |
Sell | 2,382 @ $332.38 | $791.73 K | 351,076 | 03/12/2025 | 03/14/2025 | |
|
CRAVES FRED B
Director |
Sell | 800 @ $333.66 | $266.93 K | 350,276 | 03/12/2025 | 03/14/2025 | |
|
CRAVES FRED B
Director |
Sell | 200 @ $334.97 | $66.99 K | 350,076 | 03/12/2025 | 03/14/2025 | |
|
CRAVES FRED B
Director |
Sell | 1,587 @ $330.54 | $524.56 K | 356,217 | 03/12/2025 | 03/14/2025 | |
|
Dier Mardi
SVP and CFO |
Sell | 258 @ $323.04 | $83.34 K | 10,440 | 03/10/2025 | 03/12/2025 | |
|
Waltermire Robert E.
Senior VP, Chief Pharma Dev. |
Sell | 1,777 @ $336.78 | $598.46 K | 15,164 | 03/05/2025 | 03/07/2025 | |
|
Waltermire Robert E.
Senior VP, Chief Pharma Dev. |
Sell | 1,146 @ $338.09 | $387.45 K | 14,018 | 03/05/2025 | 03/07/2025 | |
|
Waltermire Robert E.
Senior VP, Chief Pharma Dev. |
Sell | 400 @ $339.68 | $135.87 K | 13,618 | 03/05/2025 | 03/07/2025 | |
|
Waltermire Robert E.
Senior VP, Chief Pharma Dev. |
Sell | 1,657 @ $340.75 | $564.63 K | 11,961 | 03/05/2025 | 03/07/2025 | |
|
Waltermire Robert E.
Senior VP, Chief Pharma Dev. |
Sell | 1,043 @ $341.84 | $356.54 K | 10,918 | 03/05/2025 | 03/07/2025 | |
|
Waltermire Robert E.
Senior VP, Chief Pharma Dev. |
Sell | 900 @ $335.15 | $301.63 K | 16,941 | 03/05/2025 | 03/07/2025 |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Madrigal Pharmaceuticals, Inc. FAQ's
The list of insiders at Madrigal Pharmaceuticals, Inc. includes CRAVES FRED B, Kelley Shannon T, Waltermire Robert E., Taub Rebecca, Huntsman Carole, Sibold William John, Daly James M, BATE KENNETH, Dier Mardi.
Insiders have sold a total of 82.24 K Madrigal Pharmaceuticals, Inc. shares in the last 12 months for a total of 27.97 M sold.
The following insiders have sold Madrigal Pharmaceuticals, Inc. shares in the last 12 months: CRAVES FRED B ($7.41 M), Kelley Shannon T ($214.76 K), Waltermire Robert E. ($5.39 M), Taub Rebecca ($679.03 K), Huntsman Carole ($518.81 K), Sibold William John ($531.02 K), Daly James M ($5.38 M), BATE KENNETH ($7.13 M), Dier Mardi ($720.59 K),